SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-019901
Filing Date
2018-08-07
Accepted
2018-08-07 16:01:37
Documents
56
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 Q2 2018 10-Q alrn-10q_20180630.htm 10-Q 1787780
2 EX-10.1 alrn-ex101_267.htm EX-10.1 708573
3 EX-10.2 alrn-ex102_323.htm EX-10.2 77261
4 EX-10.3 alrn-ex103_324.htm EX-10.3 134989
5 EX-31.1 alrn-ex311_6.htm EX-31.1 14429
6 EX-31.2 alrn-ex312_7.htm EX-31.2 14405
7 EX-32.1 alrn-ex321_9.htm EX-32.1 7873
8 EX-32.2 alrn-ex322_8.htm EX-32.2 6941
  Complete submission text file 0001564590-18-019901.txt   6536775

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT alrn-20180630.xml EX-101.INS 1160466
10 XBRL TAXONOMY EXTENSION SCHEMA alrn-20180630.xsd EX-101.SCH 35451
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE alrn-20180630_cal.xml EX-101.CAL 34151
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE alrn-20180630_def.xml EX-101.DEF 104012
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE alrn-20180630_lab.xml EX-101.LAB 307517
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alrn-20180630_pre.xml EX-101.PRE 220462
Mailing Address 281 ALBANY STREET CAMBRIDGE MA 02139
Business Address 281 ALBANY STREET CAMBRIDGE MA 02139 617-995-0900
AILERON THERAPEUTICS INC (Filer) CIK: 0001420565 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38130 | Film No.: 18997888
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences